Opiate Substitution Treatment
Subject Areas on Research
- "Choose Physical Therapy" for Neonatal Abstinence Syndrome: Clinical Management for Infants Affected by the Opioid Crisis.
- A mixed methods study of provider factors in buprenorphine treatment retention.
- A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.
- Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.
- Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
- Anticipated Barriers to Sustained Engagement in Treatment With Medications for Opioid Use Disorder After Release From Incarceration.
- Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.
- Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence.
- Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.
- Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.
- Criminal justice continuum for opioid users at risk of overdose.
- Digital ischaemia after intra-arterial drug injection.
- Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managers.
- Facilitators and Barriers to Naloxone Kit Use Among Opioid-Dependent Patients Enrolled in Medication Assisted Therapy Clinics in North Carolina.
- Functional imaging of emotion reactivity in opiate-dependent borderline personality disorder.
- HIV, prisoners, and human rights.
- Hepatitis C Virus Treatment Delivered via Telemedicine to Persons With Opioid Use Disorder.
- Impact of Policy Change on Access to Medication for Opioid Use Disorder in Primary Care.
- Implementation of a comprehensive hospitalist-led initiative to improve care for patients with opioid use disorder.
- Influence of HIV antiretrovirals on methadone N-demethylation and transport.
- Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study.
- MOUD Provision in Correctional Settings During Time of COVID-19: Prevention and Solutions.
- Medication-Based Treatment to Address Opioid Use Disorder.
- Opioid Management in Pregnancy and Postpartum.
- Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.
- Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C).
- Patterns of withdrawal in patients with opioid use disorder (OUD) transitioning from untreated OUD or buprenorphine treatment to extended-release naltrexone.
- Post-release treatment uptake among participants of the Rhode Island Department of Corrections comprehensive medication assisted treatment program.
- Primary Care Providers And Specialists Deliver Comparable Buprenorphine Treatment Quality.
- Problem drinking and low-dose naltrexone-assisted opioid detoxification.
- Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome.
- Referring heroin users from compulsory detoxification centers to community methadone maintenance treatment: a comparison of three models.
- Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report.
- Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan.
- Tales from the frontlines: An alarming rise in hospitalizations related to opioid use disorder in the era of COVID-19.
- The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal.
- The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.
- Treatment outcomes associated with medications for opioid use disorder (MOUD) among criminal justice-referred admissions to residential treatment in the U.S., 2015-2018.
- Treatment preference for opioid use disorder among people who are incarcerated.
- Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.
- What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
Keywords of People
- Wu, Li-Tzy, Professor in Psychiatry and Behavioral Sciences, Medicine, General Internal Medicine